Stimulation of hepatic lipogenesis and acetyl-coenzyme A carboxylase by vasopressin

Biochem J. 1981 Sep 15;198(3):485-90. doi: 10.1042/bj1980485.

Abstract

The effect of vasopressin on the short-term regulation of fatty acid synthesis was studied in isolated hepatocytes from rats fed ad libitum. Vasopressin stimulates fatty acid synthesis by 30-110%. This increase is comparable with that obtained with insulin. Angiotensin also stimulates fatty acid synthesis, whereas phenylephrine does not. The dose-response curve for vasopressin-stimulated lipogenesis is similar to the dose-response curve for glycogenolysis and release of lactate plus pyruvate. Vasopression also stimulates acetyl-CoA carboxylase activity in a dose-dependent manner. Vasopressin does not relieve glucagon-inhibited lipogenesis, whereas insulin does. The action of vasopressin on hepatic lipogenesis is decreased, but not suppressed, in Ca2+-depleted hepatocytes. The results suggest that vasopressin acts on lipogenesis by increasing availability of lipogenic substrate (lactate + pyruvate) and by activating acetyl-CoA carboxylase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyl-CoA Carboxylase / metabolism*
  • Angiotensin II / pharmacology
  • Animals
  • Arginine Vasopressin / pharmacology*
  • Dose-Response Relationship, Drug
  • Glucagon / pharmacology
  • In Vitro Techniques
  • Insulin / pharmacology
  • Ligases / metabolism*
  • Lipids / biosynthesis*
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism*
  • Male
  • Rats
  • Rats, Inbred Strains
  • Stimulation, Chemical

Substances

  • Insulin
  • Lipids
  • Angiotensin II
  • Arginine Vasopressin
  • Glucagon
  • Ligases
  • Acetyl-CoA Carboxylase